Free Newsletter
Maine mulls drug take-back law
Drugmakers: Be sure to include in your supply chain plans a channel for the return of unused and expired products from consumers. Lawmakers in the Pine Tree State are considering a bill that would make manufacturers responsible for collecting unused drugs from residents and disposing of them.
The new headache for manufacturers stems from the detection of ibuprofen and acetaminophen in water at three landfills by Maine environmental officials, according to a press report. Maine's effort is one of a growing number.
Pharmaceutical manufacturers may find an ally in the medical device field: Sharps Compliance Corp., which runs a program to collect used syringes from consumers via U.S. mail, has recently launched its RxTakeAway program to dispose of unused pharmaceuticals from households. As reported earlier, biopharma companies are signing up.
- see the report
Related Articles:
Service targets home-use sharps disposal
SAFC makes room for disposables
Itero finds synergy in Xcellerex
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: